{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:44Z","timestamp":1753891604850,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Emerging evidence shows that patients with myasthenia gravis (MG) were at a higher risk for the co-occurrence of other autoimmune diseases, which reflects phenotypic heterogeneity in MG. The coexistence of MG and cryptogenic organizing pneumonia (COP) has rarely been reported. The present case is to report the coexistence of triple-seronegative MG and pathology-proven COP in a patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical data of the patient were derived from medical records of Nanjing First Hospital, Nanjing Medical University, China. Written informed consent was obtained from the patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We presented a 56-year-old man with acute respiratory syndrome, who was diagnosed with COP based on the intra-alveolar fibroinflammatory buds (Masson's bodies) in the pathology of bronchoscopy biopsy. Oral prednisone induced dramatic symptomatic improvement and complete resolution of previous lung lesions. After a stable course of no respiratory symptom for 2 months, he was referred to the neurology department with complaints of fluctuating generalized muscle weakness. He was diagnosed with triple-seronegative MG based on fluctuating weakness, neostigmine test-positivity and RNS-positivity. After three-month treatment with pyridostigmine in combination with tacrolimus, the symptoms gradually improved and he achieved minimal symptom expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case highlights the rare coexistence of triple-seronegative MG and pathology-proven COP. However, a causal association between COP and MG cannot be explicitly ascertained. In future, more data are needed to clarify the relationship, taking into account the limited number of cases reported with this coexistence of the diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1295374","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:13:26Z","timestamp":1700208806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia"],"prefix":"10.3389","volume":"14","author":[{"given":"Shi-Qi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Quan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/brainsci13091286","article-title":"Diagnosis and management of seronegative myasthenia gravis: lights and shadows","volume":"13","author":"Vinciguerra","year":"2023","journal-title":"Brain Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"790941","DOI":"10.3389\/fneur.2021.790941","article-title":"Comorbid autoimmune diseases in patients with myasthenia gravis: a retrospective cross-sectional study of a Chinese cohort","volume":"12","author":"Shi","year":"2021","journal-title":"Front Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/jnnp-2022-329284","article-title":"Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis","volume":"93","author":"Damato","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MOG.0000000000000436","article-title":"Seronegative coeliac disease: clearing the diagnostic dilemma","volume":"34","author":"Schiepatti","year":"2018","journal-title":"Curr Opin Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"103143","DOI":"10.1016\/j.autrev.2022.103143","article-title":"Seronegative autoimmune diseases: a challenging diagnosis","volume":"21","author":"Lenti","year":"2022","journal-title":"Autoimmun Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/mus.27822","article-title":"Clinical characteristics of anti-AChR-MuSK-LRP4 antibody-negative myasthenia gravis in China","volume":"67","author":"Li","year":"2023","journal-title":"Muscle Nerve."},{"key":"B10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard JF","year":"2021","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11970-1","article-title":"Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome","author":"Di Stefano","year":"2023","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00415-020-09770-y","article-title":"\u2018Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab","volume":"267","author":"Vissing","year":"2020","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"210094","DOI":"10.1183\/16000617.0094-2021","article-title":"Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease","volume":"30","author":"Raghu","year":"2021","journal-title":"Eur Respir Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1183\/09031936.96.09122513","article-title":"The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia","volume":"9","author":"Poletti","year":"1996","journal-title":"Eur Respir J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia","volume":"386","author":"King TE","year":"2022","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1479973119853829","DOI":"10.1177\/1479973119853829","article-title":"A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia","volume":"16","author":"Zhou","year":"2019","journal-title":"Chron Respir Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1378\/chest.10-0883","article-title":"Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis","volume":"139","author":"Drakopanagiotakis","year":"2011","journal-title":"Chest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0184739","DOI":"10.1371\/journal.pone.0184739","article-title":"Cryptogenic organizing pneumonia-results of treatment with clarithromycin versus corticosteroids-observational study","volume":"12","author":"Radzikowska","year":"2017","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.pulmoe.2021.02.007","article-title":"Organizing pneumonia associated with optic neuromyelitis: coincidental occurrence or causal association?","volume":"27","author":"Rimpa","year":"2021","journal-title":"Pulmonology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.resinv.2022.06.008","article-title":"Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"60","author":"Furube","year":"2022","journal-title":"Respir Investig."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1295374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:13:28Z","timestamp":1700208808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1295374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":20,"alternative-id":["10.3389\/fneur.2023.1295374"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1295374","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"article-number":"1295374"}}